Lifeboat Foundation

Researchers have developed a line immortal stem cells that allow them to generate an unlimited supply of artificial red blood cells on demand.

If these artificial blood cells pass clinical trials, they’ll be far more efficient for medical use than current red blood cell products, which have to be generated from donor blood — and would be a huge deal for patients with rare blood types, who often struggle to find matching blood donors.

The idea isn’t for these immortal stem cells to replace blood donation altogether — when it comes to regular blood transfusions, donated blood still does the trick.

Continue reading “Immortal Stem Cells Let Scientists Create an Unlimited Supply of Artificial Blood” »

Ingenious e-skin invented by scientists from the University of Glasgow improves the performance of prosthetic limbs through sensitive sensors.

History has shown us that only violence or huge disasters tend to reduce inequality. Which is frightening on it’s own.

The Great Leveller: Violence and the History of Inequality from the Stone Age to the Twenty-First Century By Walter Scheidel. Princeton University Press; 504 pages; $35 and £27.95.

AS A supplier of momentary relief, the Great Depression seems an unlikely candidate. But when it turns up on page 363 of Walter Scheidel’s “The Great Leveler” it feels oddly welcome. For once—and it is only once, for no other recession in American history boasts the same achievement—real wages rise and the incomes of the most affluent fall to a degree that has a “powerful impact on economic inequality”. Yes, it brought widespread suffering and dreadful misery. But it did not bring death to millions, and in that it stands out.

Continue reading “The lessons of violence and inequality through the ages” »

In case you missed it, Elon Musk is rather concerned about the fate of humanity, given the extreme advancements being made in artificial intelligence (AI). Ultimately, he fears that our AI will, one day, overtake us. When this happens, he claims that humans will likely become second class citizens (or slaves, or something even worse).

Now, reports have surfaced which assert that he is backing a brain-computer interface venture that was founded to allow humans to keep up with the advancements made in machines. The interface is intended to work by augmenting that which makes us human: our brains.

Continue reading “Elon Musk Just Launched A Company To Merge Your Brain With A Computer” »

Somewhere in his packed schedule, he has found time to start a neuroscience company that plans to develop cranial computers, most likely to treat intractable brain diseases first, but later to help humanity avoid subjugation at the hands of intelligent machines.

Empresário Elon Musk tem uma nova empresa — sim, outra — focada no desenvolvimento das capacidades do cérebro através do aumento tecnológico. O Neuralink, vai trabalhar em tecnologia de interface computador-cérebro como meio de ajudar os seres humanos a acompanhar o desenvolvimento acelerado de inteligência artificial.

This is big: Is the Singularity a step closer?

Tesla Inc founder and Chief Executive Elon Musk has launched a company called Neuralink Corp through which computers could merge with human brains, the Wall Street Journal reported, citing people familiar with the matter.

Neuralink is pursuing what Musk calls the “neural lace” technology, implanting tiny brain electrodes that may one day upload and download thoughts, the Journal reported. (on.wsj.com/2naUATf)

Continue reading “Elon Musk’s new co could allow uploading, downloading thoughts: Wall Street Journal” »

“In today’s world, we are increasingly hearing calls for global competencies; that is, we are seeing demand for skills such as critical thinking and creativity across both manual and professional occupations.”

Read more

An exclusive interview with Ichor, the biotech company pioneering a SENS based repair therapy that could help cure age related blindness.

Check out our exclusive interview with Ichor the company taking the first SENS based therapy to the clinic. Should clinical trials be a success this will mark the arrival of a technology that addresses one of the aging processes.